ACS Chemical Neuroscience Molecule Spotlight on Viibryd (Vilazodone)

作者：Hopkins Corey R^*

来源：ACS Chemical Neuroscience, 2011, 2(10): 554-554.

DOI：10.1021/cn200084v

• Depression
• major depressive disorder
• antidepressant
• SSRI

On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.

• 出版日期2011-10